LIVN Q1 2025 Earnings — LivaNova PLC Revenue & Financial Results | Market Cap Arena

LIVNLivaNova PLC

$3B

Q1 2025 Earnings

Healthcare Medical - Devices

Income Statement

Revenue

$317M+7.4% YoY

Gross Profit

$221M69.7% margin

Operating Income

$49M15.3% margin

Net Income

-$327M-103.3% margin

EPS (Diluted)

$-6.01

QoQ Revenue Growth

-1.5%

Cash Flow

Operating Cash Flow

$24M

Free Cash Flow

$13M

Stock-Based Comp.

$8M

Balance Sheet

Total Assets

$2.6B

Total Liabilities

$1.5B

Stockholders' Equity

$1.0B

Cash & Equivalents

$738M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$317M	$295M	+7.4%
Gross Profit	$221M	$207M	+6.5%
Operating Income	$49M	$16M	+199.3%
Net Income	-$327M	-$42M	-680.4%

Revenue Segments

Cardiopulmonary Segment

$176M56%

Neuromodulation Segment

$139M44%

Geographic Segments

UNITED STATES

$169M53%

Locations Excluding The United States And Europe

$88M28%

Europe

$60M19%